Abstract
Objective: To study the anti-inflammatory effect of neem seed oil (NSO) on albino rats using carrageenan-induced hind paw edema. Materials and Methods: The study sample was divided into six groups with each group consisting of six rats as follows: Group I: Control (distilled water 0.5 ml/rat); Group II: Standard (aspirin 200 mg/kg body weight orally); Groups III, IV, V, and VI (NSO 0.25 ml, 0.5 ml, 1 ml, and 2 ml/kg body weight, respectively, i.p.). The inflammation induced in the form of hind paw edema was produced by injection of 0.1 ml of 1% suspension of carrageenan in normal saline below the plantar aponeurosis of right hind paw of rats; the left hind paw served as control. The volume of edema was measured by water displacement method in microburette. Volumes of both the hind paws were measured before and after 1, 2, 3, 4, 6, 12, and 24 h of carrageenan injection. Results: NSO in the dose of 0.25 ml/kg body weight did not show any significant anti-inflammatory activity. NSO showed increased inhibition of paw edema with the progressive increase in dose from 0.25 ml to 2 ml/kg body weight. At the dose of 2 ml/kg body weight, NSO showed maximum (53.14%) inhibition of edema at 4 th hour of carrageenan injection. Aspirin in the dose of 200 mg/kg body weight showed maximum inhibition of hind paw edema. Conclusion: The present study concludes that NSO exhibits significant anti-inflammatory action.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer